1.Skin Rash.
Journal of the Korean Medical Association 1999;42(7):700-703
No abstract available.
Exanthema*
;
Skin*
2.Skin Rashes in Children.
Journal of the Korean Pediatric Society 1998;41(4):431-431
No abstract available.
Child*
;
Exanthema*
;
Humans
;
Skin*
3.Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy.
Chee Won OH ; Jimi YOON ; Chi Yeon KIM
Annals of Dermatology 2012;24(3):360-362
No abstract available.
Bacillus
;
Exanthema
;
Immunotherapy
;
Pityriasis
4.Morbilliform rashes as sole manifestation of COVID-19
The Filipino Family Physician 2021;59(1):124-126
Coronavirus Disease 2019 (Covid-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is recognized as a worldwide public health crisis. It has rapidly spread from Wuhan City in China after an outbreak of flu-like illness. Respiratory symptoms remain the most common manifestation of Covid-19. However, dermatologic manifestations have been observed in patients with COVID-19 infection. Kulkharni, et al. published a case report of morbilliform rashes as a probable herald of Covid-19 being its initial and only manifestation of COVID-19.1 This is a case of a 45-year-old female who presented with worsening morbilliform rashes on both upper extremities and was initially diagnosed with allergic contact dermatitis. She had no respiratory symptoms and was eventually diagnosed with Covid-19 in a routine Reverse Transcription Polymerase Chain Reaction test (RT-PCR). She was subsequently admitted for treatment and recovered after 2 weeks of hospital stay.
Covid-19
;
Exanthema
5.Reevaluation of the importance of finding rash, lymphadenitis and eschars for the early clinical diagnosis of Tsutsugamushi disease.
Kang Su YI ; Sung Kun YOU ; Wan KO ; Won Young LEE ; Chin Ki PAI ; Ki Il KIM ; Yunsop CHONG
Korean Journal of Infectious Diseases 1991;23(3):163-169
No abstract available.
Diagnosis*
;
Exanthema*
;
Lymphadenitis*
;
Scrub Typhus*
6.Dermatological Side Effects of Anti-tumor Necrosis Factor Alpha Therapy.
Journal of Rheumatic Diseases 2014;21(1):9-19
As anti-tumor necrosis factor alpha (anti-TNFalpha) agents are progressively being used in various medical conditions, dermatological adverse events have been encountered more frequently. To understand such dermatological conditions that have been documented while undergoing anti-TNF therapy, we reviewed relevant literature, including case reports and case series. Reported dermatological conditions included infusion and injection site reaction, cutaneous infection, psoriasiform eruption, dermatitis, allergic rash, lupus-like lesion, vasculitis, lichenoid reaction, granulomatous reaction, hair loss, cutaneous infection, and cutaneous neoplasm. These events had varying strengths of causal association and severity therefore, drug discontinuation may or may not be required.
Dermatitis
;
Exanthema
;
Hair
;
Necrosis*
;
Vasculitis
7.Symmetrical Flexural and Intertriginous Exanthema: A Rare Manifestation Associated with COVID-19 Infection
Jin Yi Goh ; Huang Hin Chin ; Pek Woon Chin ; Masliza Zaid
Malaysian Journal of Dermatology 2021;46(June 2021):55-57
Summary
Cutaneous manifestations of Coronavirus disease (COVID-19) are variable. We present a case of non-drug related symmetrical flexural and intertriginous exanthema in a patient with COVID-19 infection. A 58-year-old Chinese male who was diagnosed to have COVID-19 infection, developed maculopapular erythematous rashes at bilateral axillary and inguinal folds on the fourth day of illness. He was treated symptomatically with anti-histamine and topical corticosteroid. The skin condition improved and he was discharged well on tenth day of illness. Although symmetrical flexural intertriginous exanthema isclassically caused by drug reaction, this case demonstrated the possibility of the rash being directly associated with COVID-19 infection. More cohorts should be evaluated to fully describe the full spectrum of dermatological manifestation in COVID-19.
Exanthema
;
COVID-19
;
Skin Manifestations
8.The Effect of Bucillamine in the Initial Treatment of Rheumatoid Arthritis and Treatment of Patients with Refractory Rheumatoid Arthritis.
Chang Ho SONG ; Ji Soo LEE ; Chang Hee LEE ; Choong Won LEE ; Chang Hee SUH ; Jung Sik SONG ; Soo Kon LEE
The Journal of the Korean Rheumatism Association 1998;5(1):83-88
OBJECTIVE: To assess the clinical effect of bucillamine in rheumatoid arthritis (RA), we performed an open clinical trial for 3 months. METHODS: 10 out of 12 patients completed bucillamine trial(200mg/day) for their initial treatment against arthritis, and 9 out of 11 patients with refractory RA completed the bucillamine trial. Disease activity was assessed by the duration of morning stiffness(MS), visual analogue pain scale(VAPS), functional capacity(FC), tender joint counts(TJC), swollen joint counts(SJC), ESR, and CRP every month. Adverse effects were monitored monthly. RESULTS: At the end of trial, all parameters were decreased in the initial treatment group except of CRP. No parameters were decreased in the refractory group. Gastrointestinal disturbance was the most commmon adverse effect. Skin rash, stomatitis, proteiuria and elevated hepatic enzyme were minor adverse effects. CONCLUSION: Bucillamine was effective in the initial treatment of rheumatoid arthritis, but not effective in the patients with refractory rheumatoid arthritis. Bucillamine is relatively safe in the treatment of rheumatoid arthritis in both groups.
Arthritis
;
Arthritis, Rheumatoid*
;
Exanthema
;
Humans
;
Joints
;
Stomatitis
10.Three Cases of Eruptive Pseudoangiomatosis in Adults.
Yoon Young KIM ; Mi Yeon KIM ; Young Min PARK ; Hyung Ok KIM
Korean Journal of Dermatology 2006;44(6):727-730
Eruptive pseudoangiomatosis (EPA) is a rare, benign, spontaneously-regressing exanthem. The term EPA was to describe a dermatosis characterized by the sudden onset of a few to several bright red angioma-like papules which is different histopathologically from true angioma. Herein we describe three cases of typical EPA in adults and review the literature. Based on our experience, it is likely that EPA has been misdiagnosed or underdiagnosed in the clinic and that it occurs more frequently in adults than previously reported.
Adult*
;
Exanthema
;
Hemangioma
;
Humans
;
Skin Diseases